Reviews Write New Review
Report a problem with this profile
[email protected]
[email protected]
Jim Tananbaum
CEO and Managing Director, Foresite Capital
Foresite Capital CEO Jim Tananbaum, a newcomer to this year's Midas List, has had notable hits in the last five years in Puma Biotechnology and Intarcia Therapeutics. Before Foresite, Tananbaum was a founding partner of Prospect Venture Partners II and III and was founder and CEO of Theravance (current market cap of $3.5 billion). Early in his career, Tananbaum was a partner at Sierra Ventures and helped establish its healthcare service investment practice. Other investments led by Tananbaum include Amira Pharmaceuticals (acquired Bristol Myers-Squibb), Amerigroup (IPO), Healtheon, and Jazz Pharmaceuticals (IPO).
Related Speakers View all
Mitch Lasky
Benchmark Capital, General Partner
|
|
Jeffrey Low
Partner at Andreessen Horowitz
|
|
Eric Paley
Managing partner at Founder Collective, Entrepreneur...
|
|
Jeff Crowe
Managing Partner, Norwest Venture Partners
|
|
Jonathan Silverstein
General Partner, OrbiMed
|
|
Asheem Chandna
Partner, Greylock Partners
|
|
Hurst Lin
General Partner, DCM
|
|
Salil Deshpande
Managing Director, Bain Capital Ventures
|
|
Steven Ji
Partner, Sequoia Capital China
|
|
Nina Kjellson
Board Member at Essential Access Health, Lycera & Annum
|
|
Joe Lonsdale
Formation 8 Partner
|
|
Bryan Schreier
Currently sits on the board of Dropbox, Hearsay, Qua...
|
|
Andrew Braccia
Partner, Accel Partners
|
|
George Zachary
Charles River Ventures
|
|
Bill Trenchard
Founder partner at Founder Collective, board member ...
|
|
Kevin Efrusy
Kevin Efrusy is a General Partner at Accel Managemen...
|
|
Florian Otto
CEO and Co-Founder at Cedar, Inc.
|
|
Shaista Asif
Co-Founder & Group COO of PureHealth
|
|
Gregory Shepard
Co-Founder BOSS Capital Partners & BOSS Startup Scie...
|
|
Adam Boehler
Chief Executive Officer at Rubicon Founders
|